MAIA Biotechnology Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 ‘-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
/ 
Frequently asked questions
To buy MAIA Biotechnology Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for MAIA Biotechnology Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for MAIA Biotechnology Inc. is MAIA:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
MAIA Biotechnology Inc. has its primary listing on NYSE American. You can trade MAIA Biotechnology Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, MAIA Biotechnology Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include MAIA Biotechnology Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like MAIA Biotechnology Inc..